Table 2 List of diagnosis and their relative treatment plans

G. I-II (22)

OG. (12)

Ph. (1)

\(2\times 30\)

15*

Pr. (11)

\(1.8\times 28\)-30-33

AC. (10)

Ph. (3)

\(3.4\times 10; 2\times 30\)

Pr. (7)

\(1.8\times 28\)-30

Anaplastic G. II (7)

Anaplastic OG. (1)

Pr. (1)

\(1.8\times 33\)

20*

Anaplastic AC. (6)

Ph. (4)

\(2\times 30\)

Pr. (2)

\(1.8\times 33\)

GB. III-IV (51)

AC. III (2)

Ph. (2)

\(3.5\times 10; 2.67\times 15\)

20*

OG. III (2)

Ph. (1)

\(2.67\times 15\)

Pr. (1)

\(1.8\times 33\)

GB. IV (47)

Ph. (46)

3.4–\(3.5\times 10; 2.67\times 15; 2\times 30\)

Pr. (1)

\(1.8\times 28\)

Menigiomas (8)

Meningioma I (6)

Pr. (6)

\(1.8\times 28\)-30-33;

2–5*

Meningioma II (1)

Pr. (1)

\(1.8\times 30\)

5–10*

HmngP. II-III (1)

Ph. (1)

\(2\times 30\)

**

Benign Neoplasms (2)

Craniopharingioma (1)

Pr. (1)

\(1.8\times 28\)

1.5*

Schwannoma (1)

Pr. (1)

\(1.8\times 28\)

**

Metastasis (9)

Ph. (9)

\(6\times 5\)

CTV = GTV

Neuroendocrine T. (1)

Embryonic T. (1)

Ph. (1)

\(6\times 5\)

**